Genomic Health

Health genetics medical diagnostics oncology

Genomic Health, Inc. is the provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The Company is applying its scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring.

Revenue(FY, 2017)

$340.8 M

Market capitalization(2018-04-23)

$1.1 B

Type

Public

Redwood City, US

Founded

2000

Size (employees)

846 (est)

Website

genomichealth.com

Genomic Health was founded in 2000 and is headquartered in Redwood City, US

Report incorrect company information

Genomic Health Office Locations

Genomic Health has an office in Redwood City

Redwood City, US (HQ)

301 Penobscot Dr

Show all (1)

Report incorrect company information

Genomic Health Financials and Metrics

Genomic Health Financials

Genomic Health's revenue was reported to be $340.75 m in FY, 2017

Summary

USD
Revenue (FY, 2017)	340.8 m
Net income (FY, 2017)	(3.9 m)
EBIT (FY, 2017)	(6.5 m)
Market capitalization (23-Apr-2018)	1.1 b
Cash (31-Dec-2017)	45.5 m

Genomic Health's current market capitalization is $1.1 b.

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	261.6 m	275.7 m	287.5 m	327.9 m	340.8 m
Revenue growth, %		5%	4%	14%
Sales and marketing expense					157 m
General and administrative expense					72.7 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Revenue	66 m	67 m	70.5 m	69.1 m					82 m	82.3 m		85.5 m
General and administrative expense	14 m	14.7 m	15 m	15 m	15.6 m	16.6 b	16.4 b	18.4 m	18.5 m	18.3 m	16.8 m	18.4 m
R&D expense	14.7 m	14.7 m	13.3 m	14.7 m	19.1 m	14.6 b	13.5 b	16 m	15.3 m	15.1 m	14.9 m	15.8 m
Operating expense total	65.5 m	74.2 m	75.1 m	74.9 m	82.8 m	81.5 b	79 b	89.7 m	87.1 m	85.3 m	86.8 m	88.6 m

show all

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	33.3 m	29.7 m	32.5 m	40.4 m	45.5 m
Accounts Receivable	29.4 m	34.9 m	37.2 m	35.2 m	31.2 m
Inventories	10.2 m	9.9 m	10.8 m	13.8 m
Current Assets	145 m	148.5 m	143 m	146 m	174.3 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Cash	39.8 m	28.2 m	32.5 m	37.2 m	22.9 m	23.8 m	28 m	30.7 m	40.7 m	34 m	40.8 m	42.2 m
Accounts Receivable	25.6 m	28.9 m	31.8 m	31 m	35 m	32.9 m	33.8 m	38.8 m	33.6 m	33.7 m	34.6 m	32.4 m
Current Assets	149 m	139.9 m	146.5 m	145.2 m	175 m	162.4 m	142 m	136.6 m	139 m	144.3 m	142.1 m	154.5 m
PP&E	18.2 m	18.1 m	17.3 m	18.1 m	25.2 m	28.6 m	34.7 m	39.3 m	39.1 m	39.5 m	49.5 m	48.9 m

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	(12.8 m)	(24.6 m)	(33.3 m)	(13.9 m)	(3.9 m)
Depreciation and Amortization	6.3 m		7.1 m	8.9 m	11.8 m
Inventories		9.9 m
Accounts Payable	1.2 m	7 m	949 k	(4.6 m)	(2.3 m)

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Net Income	488 k	(7.4 m)	(4.6 m)	(6.3 m)	(9.5 m)	(18.7 m)	(30.6 m)	(6.4 m)	(12.5 m)	(15.3 m)	(806 k)	(3.5 m)
Depreciation and Amortization						3.4 m	5.1 m	2.2 m	4.4 m	6.7 m	2.4 m	5.4 m
Accounts Payable			5.6 m	5.9 m	8 m	(730 k)	(1.8 m)	(2.4 m)	(2.4 m)	(2 m)	2.2 m	2.2 m
Cash From Operating Activities						(10.7 m)	(9.6 m)	(5.3 m)	1.8 m	10.6 m	765 k	11.9 m